Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We previously identified two ASD risk genes encoding the receptor tyrosine kinase MET and the urokinase plasminogen activator receptor (PLAUR), which is thought to modulate availability of the MET ligand.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP873991.RAhmovULupAgS-BBtsz4a8n4jrH4OpcsROchdi30J1QvY130_assertion description "[We previously identified two ASD risk genes encoding the receptor tyrosine kinase MET and the urokinase plasminogen activator receptor (PLAUR), which is thought to modulate availability of the MET ligand.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873991.RAhmovULupAgS-BBtsz4a8n4jrH4OpcsROchdi30J1QvY130_provenance.
• NP483544.RA2LJNLOLbFN3rWM_VOhhMFwGZXeyiPv-Yi5lC6UkFkWw130_assertion description "[We previously identified two ASD risk genes encoding the receptor tyrosine kinase MET and the urokinase plasminogen activator receptor (PLAUR), which is thought to modulate availability of the MET ligand.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP483544.RA2LJNLOLbFN3rWM_VOhhMFwGZXeyiPv-Yi5lC6UkFkWw130_provenance.
• NP706786.RAWjcpvCwaWiNf0zVFUyRQYegdrESYwT1t5N7sh7df_h8130_assertion description "[We previously identified two ASD risk genes encoding the receptor tyrosine kinase MET and the urokinase plasminogen activator receptor (PLAUR), which is thought to modulate availability of the MET ligand.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP706786.RAWjcpvCwaWiNf0zVFUyRQYegdrESYwT1t5N7sh7df_h8130_provenance.
• NP706827.RAUXBmMiOSAUwd8PIUuuIR0mh-64xZTdxG8c5halAmtT4130_assertion description "[We previously identified two ASD risk genes encoding the receptor tyrosine kinase MET and the urokinase plasminogen activator receptor (PLAUR), which is thought to modulate availability of the MET ligand.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP706827.RAUXBmMiOSAUwd8PIUuuIR0mh-64xZTdxG8c5halAmtT4130_provenance.
• NP685784.RA8BBxip9VUk_EVVonrNPdIk_EV4_z4PcyMh4sQAuOe8g130_assertion description "[We previously identified two ASD risk genes encoding the receptor tyrosine kinase MET and the urokinase plasminogen activator receptor (PLAUR), which is thought to modulate availability of the MET ligand.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685784.RA8BBxip9VUk_EVVonrNPdIk_EV4_z4PcyMh4sQAuOe8g130_provenance.
• NP553988.RAXieUJ5o2MqEotaifq3jk4hWYWT7etmax7TV9l4rQCVg130_assertion description "[We previously identified two ASD risk genes encoding the receptor tyrosine kinase MET and the urokinase plasminogen activator receptor (PLAUR), which is thought to modulate availability of the MET ligand.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553988.RAXieUJ5o2MqEotaifq3jk4hWYWT7etmax7TV9l4rQCVg130_provenance.
• assertion description "[We previously identified two ASD risk genes encoding the receptor tyrosine kinase MET and the urokinase plasminogen activator receptor (PLAUR), which is thought to modulate availability of the MET ligand.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We previously identified two ASD risk genes encoding the receptor tyrosine kinase MET and the urokinase plasminogen activator receptor (PLAUR), which is thought to modulate availability of the MET ligand.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP873206.RAWz5SVWpYMJYk_o699y1Qrxokrm-C3hoC5k0uKJL1i0c130_assertion description "[We previously identified two ASD risk genes encoding the receptor tyrosine kinase MET and the urokinase plasminogen activator receptor (PLAUR), which is thought to modulate availability of the MET ligand.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873206.RAWz5SVWpYMJYk_o699y1Qrxokrm-C3hoC5k0uKJL1i0c130_provenance.
• NP630127.RAocKls7Znis6FxxiZoV6chUSIPP8Cqna3dqKtI9PHnMo130_assertion description "[We previously identified two ASD risk genes encoding the receptor tyrosine kinase MET and the urokinase plasminogen activator receptor (PLAUR), which is thought to modulate availability of the MET ligand.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630127.RAocKls7Znis6FxxiZoV6chUSIPP8Cqna3dqKtI9PHnMo130_provenance.
• NP873205.RAn_9vJxNY4Wyz6Gcxay0YbD4paSI-hDMBOA6VJ1uPwQk130_assertion description "[We previously identified two ASD risk genes encoding the receptor tyrosine kinase MET and the urokinase plasminogen activator receptor (PLAUR), which is thought to modulate availability of the MET ligand.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873205.RAn_9vJxNY4Wyz6Gcxay0YbD4paSI-hDMBOA6VJ1uPwQk130_provenance.
• NP802858.RAEmgDyWAMueQbtFWrYBXCHl6fPwYWwWo3_LbfdhtMxXc130_assertion description "[We previously identified two ASD risk genes encoding the receptor tyrosine kinase MET and the urokinase plasminogen activator receptor (PLAUR), which is thought to modulate availability of the MET ligand.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802858.RAEmgDyWAMueQbtFWrYBXCHl6fPwYWwWo3_LbfdhtMxXc130_provenance.
• NP873203.RAO96cy4pq743mvP3ubb6oC-xGrMvBrfF8VeICNMXx7pY130_assertion description "[We previously identified two ASD risk genes encoding the receptor tyrosine kinase MET and the urokinase plasminogen activator receptor (PLAUR), which is thought to modulate availability of the MET ligand.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873203.RAO96cy4pq743mvP3ubb6oC-xGrMvBrfF8VeICNMXx7pY130_provenance.
• NP873208.RAN55uYolF38uSbvnlL-ph4rknNMh57v1SBUiiHiYDpno130_assertion description "[We previously identified two ASD risk genes encoding the receptor tyrosine kinase MET and the urokinase plasminogen activator receptor (PLAUR), which is thought to modulate availability of the MET ligand.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873208.RAN55uYolF38uSbvnlL-ph4rknNMh57v1SBUiiHiYDpno130_provenance.
• NP945801.RAxYg-xmnS-n1qVPg5__Tk0PQj76VtmWV1juqFWpipRZw130_assertion description "[We previously identified two ASD risk genes encoding the receptor tyrosine kinase MET and the urokinase plasminogen activator receptor (PLAUR), which is thought to modulate availability of the MET ligand.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945801.RAxYg-xmnS-n1qVPg5__Tk0PQj76VtmWV1juqFWpipRZw130_provenance.